Vertaling van "project and increase the number " (Nederlands → Frans) :

The following campaigns were undertaken in 2008 in order to publicise the project and increase the number of reports and improve their quality:
The following campaigns were undertaken in 2008 in order to publicise the project and increase the number of reports and improve their quality:

Net income rose 1% to USD 2.1 billion as the 13% increase in Group operating income was largely offset by a loss from associated companies due to USD 189 million of charges for Roche’s restructuring of Genentech and an Alcon-related R&D project impairment, increased financing costs and a higher tax rate.
Le résultat net a augmenté de 1% à USD 2,1 milliards, car la hausse de 13% du résultat opérationnel du Groupe a été largement contrebalancée par une perte provenant des sociétés associées en raison de charges d’USD 189 millions pour la restructuration de Genentech par Roche et d’une perte de valeur pour un projet de R&D lié à Alcon, d’un accroissement des coûts de financement et du taux d’imposition.

One striking point is the clear trend towards an increasing number of phase I trials, from 17% in 2004 to 24% in 2007, as well as the increase in the number of submitted academic clinical trials: from 3% in 2004 to 7% in 2007.
One striking point is the clear trend towards an increasing number of phase I trials, from 17% in 2004 to 24% in 2007, as well as the increase in the number of submitted academic clinical trials: from 3% in 2004 to 7% in 2007.

Some current and future projects of the Veterinary Medicines unit In addition to active participation in numerous projects with an impact on different departments or services or even on the entire organisation, there are also a number of projects specifically for the Veterinary Medicines unit, such as: ●● The computerisation of the databases for
Some current and future projects of the Veterinary Medicines unit In addition to active participation in numerous projects with an impact on different departments or services or even on the entire organisation, there are also a number of projects specifically for the Veterinary Medicines unit, such as: ●● The computerisation of the databases for

In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.
In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.

There was an increase in the total number of applications for evaluation, with a significant rise in particular in the number of PSUR.
There was an increase in the total number of applications for evaluation, with a significant rise in particular in the number of PSUR.

What makes this phenomenon all the more worrying is that the death rate increases with the number of attempted suicides, desperate individuals making use of increasingly violent means.
Ce phénomène est d’autant plus inquiétant que la létalité augmente au fil des tentatives, le désespéré ayant recours à des moyens de plus en plus violents.

Whereas there were 58 programmable inspections (routine + new inspections) of GMP companies in 2007, the increase in the number of personnel during the year means that 122 such inspections can be planned for 2008.
Whereas there were 58 programmable inspections (routine + new inspections) of GMP companies in 2007, the increase in the number of personnel during the year means that 122 such inspections can be planned for 2008.

Finally, in 2008 the Special Investigation Unit (SOE-USE) started its work. This unit is charged with combating pharmaceutical crime and is of extreme importance given the significant increase in the number of cases of counterfeits.
Finally, in 2008 the Special Investigation Unit (SOE-USE) started its work. This unit is charged with combating pharmaceutical crime and is of extreme importance given the significant increase in the number of cases of counterfeits.

Core operating income, which excluded higher impairment and other exceptional charges of USD 22 million in 2009 over the 2008 period, grew 19% to USD 248 million as productivity gains and cost controls helped free up resources for increased Marketing & Sales investments for the launch of Prevacid24HR in the US and R&D projects.
Le résultat opérationnel «core», qui exclut une augmentation de pertes de valeur et autres charges exceptionnelles d'un montant d'USD 22 millions au quatrième trimestre 2009 par rapport à la même période de 2008, s'est élevé à USD 248 millions, en hausse de 19%.